Histogenics Corporation

NASDAQ: HSGXHealthcare / Biotechnology / USA
0.190000.00Vol 6 495 5541Y Perf -93.18%
Jun 24th, 2019 15:59
BID0.1900 ASK0.1900
Open0.1800 Previous Close0.1900
Pre-Market0.18 After-Trading0.20
 -0.01 -5.26%  0.01 5.26%
Target Price
1.50 
Analyst Rating
Hold 3.00
Potencial %
689.47 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/33 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/39 
Income Ranking
 —    -
Market Cap (mil)18 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
3.77 
Earnings Date
8th Aug 2019

Today's Price Range

0.18000.1900

52wk Range

0.08003.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
11.76%
3 Months
58.33%
6 Months
46.15%
1 Year
-93.18%
3 Years
-89.39%
5 Years
-

Name / TickerPriceChg.Chg.%
HSGX0.19000.00000.00
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.01-0.06-500.00
Q03 2018-0.19-0.24-26.32
Q02 2018-0.22-0.25-13.64
Q01 2018-0.07-0.20-185.71
Q04 2017-0.31-0.2616.13
Q03 2017-0.30-0.2323.33
Q02 2017-0.31-0.2519.35
Q01 2017-0.48-0.2645.83
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.010.00-
9/2019 QR-0.010.00-
12/2019 FY-0.030.00-
12/2020 FY-0.030.00-
Next Report Date8th Aug 2019
Estimated EPS Next Report-0.01
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume6 495 554
Shares Outstanding (in ths.)94 599
Trades Count4 638
Dollar Volume1 163 843
Avg. Volume10 373 250
Avg. Weekly Volume7 883 118
Avg. Monthly Volume11 951 904
Avg. Quarterly Volume10 669 211
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

Histogenics Corporation

Histogenics Corp is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The company's first product candidate, NeoCart, is an tissue implant that utilizes various aspects of regenerative medicine platform to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. Histogenics operates in two geographic regions: The United States (Massachusetts) and Israel (Tel Aviv). Regenerative medicine technologies encompass a variety of therapeutic approaches, including tissue engineering, cell-based therapies, gene therapy, small molecules and biologics, stem cells and biobanking.

CEO:

Teplephone: +1 781 547-7900

Address: 830 Winter Street, Waltham 02451, MA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

74%26%

Bearish Bullish

55%45%

Bearish Bullish

61%39%

News